Design
Review
Authors
Loading...
Does not support changing RAS inhibitor use; leaves open tissue-specific targeting for future trials.
Key points are not available for this paper at this time.
Shunichi et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: